Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marco L. Davila"'
Autor:
Justin C, Boucher, Bin, Yu, Gongbo, Li, Bishwas, Shrestha, David, Sallman, Ana Marie, Landin, Cheryl, Cox, Kumar, Karyampudi, Claudio, Anasetti, Marco L, Davila, Nelli, Bejanyan
Publikováno v:
Journal of Immunotherapy. 46:5-13
Higher γδ T cell counts in patients with malignancies are associated with better survival. However, γδ T cells are rare in the blood and functionally impaired in patients with malignancies. Promising results are reported on the treatment of vario
Autor:
Marco L. Davila, Justin C. Boucher
Publikováno v:
The Cancer Journal. 27:92-97
The US Food and Drug Administration has approved 3 chimeric antigen receptor (CAR) T-cell therapies. For continued breakthroughs, novel CAR designs are needed. This includes different antigen-binding domains such as antigen-ligand binding partners an
Autor:
Marco L. Davila, Kendra Sweet, Linda Kelley, Bin Yu, Xuefeng Wang, Justin C. Boucher, Ho-chien Tsai, Nolan J. Beatty, Jeffrey E. Lancet, Yongliang Zhang, Asmita Mishra, Gongbo Li, Bishwas Shrestha
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
Supplemental Digital Content is available in the text.
Adoptive cell therapy with ex vivo expanded tumor infiltrating lymphocytes or gene engineering T cells expressing chimeric antigen receptors (CAR) is a promising treatment for cancer patient
Adoptive cell therapy with ex vivo expanded tumor infiltrating lymphocytes or gene engineering T cells expressing chimeric antigen receptors (CAR) is a promising treatment for cancer patient